94 participants
Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-07
- Start Date:
- 2026-02-10
- Completion:
- 2029-12-01
Conditions
- Pneumonitis
- Immune-related Adverse Event
Interventions
- DRUG
- OTHER
No Results Yet